Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 28;31(11):3219-3226.
doi: 10.1016/j.numecd.2021.07.030. Epub 2021 Aug 5.

The association between BMI and metabolically unhealthy status with COVID-19 mortality: Based on 3019 inpatients from Wuhan, China

Jing Zeng  1 , Xiong Liu  2 , Shengshu Wang  3 , Shanshan Yang  4 , Wangping Jia  3 , Ke Han  3 , Changjun Wang  2 , Miao Liu  5 , Yong Chen  6 , Yao He  7
Affiliations

The association between BMI and metabolically unhealthy status with COVID-19 mortality: Based on 3019 inpatients from Wuhan, China

Jing Zeng et al. Nutr Metab Cardiovasc Dis. .

Abstract

Background and aims: Patients with multiple metabolic diseases are at high risk for the occurrence and death of COVID-19. Little is known about patients with underweight and metabolically healthy obesity. The aim of this study is to evaluate the impact of BMI and COVID-19 mortality in hospitalized patients, and also explore the association in different metabolically healthy (MHS) and unhealthy status (MUS).

Methods and results: A retrospective cohort study based on 3019 inpatients from Wuhan was conducted. Included patients were classified into four groups according the BMI level (underweight, normal weight, overweight and obesity), and patients with at least one of the metabolic abnormalities (diabetes, hypertension, dyslipidemia) was defined as MUS. Multiple Cox model was used to calculate the hazard ratio (HR). Compared to patients with normal weight, the HRs of overweight and obesity for COVID-19 mortality were 1.91 (95%CI:1.02-3.58) and 2.54 (95%CI:1.22-5.25) respectively in total patients, and 2.58 (95%CI:1.16-5.75) and 3.89 (95%CI:1.62-9.32) respectively in the elderly. The HR of underweight for COVID-19 mortality was 4.58 (95%CI:1.56-13.48) in the elderly. For different metabolic statuses, both underweight, overweight and obesity had obviously negative association with COVID-19 mortality in total and elderly patients with MUS. However, no significance was found in non-elderly and patients with MHS.

Conclusion: Not only overweight or obesity, but also underweight can be associated with COVID-9 mortality, especially in the elderly and in patients with MUS. More large-scale studies are needed for patients with underweight and metabolically healthy overweight or obesity.

Keywords: COVID-19; Cohort study; Metabolic unhealth; Obesity; Underweight.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The author has no conflict of interest to declare.

Figures

Figure 1
Figure 1
Flow chart of inclusion of patients.
Figure 2
Figure 2
The distribution of BMI groups.
See this image and copyright information in PMC

References

    1. Ioannidis J.P.A. Global perspective of COVID-19 epidemiology for a full-cycle pandemic. Eur J Clin Invest. 2020;50:e13423. - PMC - PubMed
    1. Singh A.K., Gillies C.L., Singh R., Singh A., Chudasama Y., Coles B., et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metabol. 2020;22:1915–1924. - PMC - PubMed
    1. Yu W., Rohli K.E., Yang S., Jia P. Impact of obesity on COVID-19 patients. J Diabet Complicat. 2021;35:107817. - PMC - PubMed
    1. Ma S., Xi B., Yang L., Sun J., Zhao M., Bovet P. Trends in the prevalence of overweight, obesity, and abdominal obesity among Chinese adults between 1993 and 2015. Int J Obes. 2021;45:427–437. - PubMed
    1. Bai R., Wu W., Dong W., Liu J., Yang L., Lyu J. Forecasting the populations of overweight and obese Chinese adults. Diabetes Metab Syndr Obes. 2020;13:4849–4857. - PMC - PubMed

Publication types